EA200700600A1 - Фармацевтическая композиция, содержащая изомер бета-миметического агента и антихолинергический агент - Google Patents

Фармацевтическая композиция, содержащая изомер бета-миметического агента и антихолинергический агент

Info

Publication number
EA200700600A1
EA200700600A1 EA200700600A EA200700600A EA200700600A1 EA 200700600 A1 EA200700600 A1 EA 200700600A1 EA 200700600 A EA200700600 A EA 200700600A EA 200700600 A EA200700600 A EA 200700600A EA 200700600 A1 EA200700600 A1 EA 200700600A1
Authority
EA
Eurasian Patent Office
Prior art keywords
agent
pharmaceutical composition
betumepholic
composition containing
cholinergic
Prior art date
Application number
EA200700600A
Other languages
English (en)
Inventor
Амар Лулла
Джина Малхотра
Original Assignee
Сипла Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сипла Лимитед filed Critical Сипла Лимитед
Publication of EA200700600A1 publication Critical patent/EA200700600A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Фармацевтическая композиция в дозированной форме, приемлемой для ингаляции, содержащая терапевтически эффективный изомер бета-миметического агента или его соль, сольват, эфир, производное или полиморф, по существу, свободный от менее терапевтически эффективного(ых) изомера(ов) указанного агента и необязательно антихолинергический агент или его соль, сольват, эфир, производное, изомер или полиморф. Предпочтительно композиция содержит сульфат R-сальбутамола и бромид ипратропия. Также представлены способы получения композиций по изобретению.
EA200700600A 2004-09-09 2005-09-09 Фармацевтическая композиция, содержащая изомер бета-миметического агента и антихолинергический агент EA200700600A1 (ru)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
IN970MU2004 2004-09-09
IN1004MU2004 2004-09-17
IN1077MU2004 2004-10-08
IN1088MU2004 2004-10-11
IN1089MU2004 2004-10-11
IN93MU2005 2005-01-31
IN222MU2005 2005-02-28
PCT/GB2005/003475 WO2006027595A1 (en) 2004-09-09 2005-09-09 Pharmaceutical composition comprising an isomer of a betamimetic agent and an anti-cholinergic agent

Publications (1)

Publication Number Publication Date
EA200700600A1 true EA200700600A1 (ru) 2008-02-28

Family

ID=35311711

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700600A EA200700600A1 (ru) 2004-09-09 2005-09-09 Фармацевтическая композиция, содержащая изомер бета-миметического агента и антихолинергический агент

Country Status (11)

Country Link
US (1) US20070264202A1 (ru)
EP (1) EP1791534A1 (ru)
JP (1) JP2008512434A (ru)
KR (1) KR20070102659A (ru)
AU (1) AU2005281511B2 (ru)
BR (1) BRPI0515103A (ru)
CA (1) CA2580019A1 (ru)
EA (1) EA200700600A1 (ru)
IL (1) IL181828A0 (ru)
MX (1) MX2007002899A (ru)
WO (1) WO2006027595A1 (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
CA2652699C (en) 2006-05-19 2014-11-04 Boehringer Ingelheim International Gmbh Propellant-free inhalation aerosol formulation containing ipratropium bromide and salbutamol sulfate
EP2026784A1 (de) * 2006-05-19 2009-02-25 Boehringer Ingelheim International GmbH Aerosolformulierung enthaltend ipratropiumbromid und salbutamolsulfat
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20110250242A1 (en) * 2008-10-23 2011-10-13 Sunovion Pharmaceuticals Inc. Arformoterol and tiotropium compositions and methods for use
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
PE20130036A1 (es) 2009-11-25 2013-02-03 Boehringer Ingelheim Int Nebulizador
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
CN106255554B (zh) 2014-05-07 2021-05-04 勃林格殷格翰国际有限公司 容器、喷雾器及用途
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
ES2957901T3 (es) 2014-05-07 2024-01-29 Boehringer Ingelheim Int Recipiente y dispositivo indicador y nebulizador
EP3569221A1 (en) * 2018-05-17 2019-11-20 Notoxins IP B.V. Aqueous formulations comprising ipratropium for topical treatment of hyperhidrosis
CN113018280A (zh) * 2021-03-01 2021-06-25 石家庄四药有限公司 一种异丙托溴铵吸入用溶液制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5919827A (en) * 1990-07-11 1999-07-06 Sepracor Inc. Method for treating asthma using optically pure R(-) salmeterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6299863B1 (en) * 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
GB9827200D0 (en) * 1998-12-11 1999-02-03 Glaxo Group Ltd Dry powder inhaler
WO2001064274A2 (en) * 2000-03-01 2001-09-07 Glaxo Group Limited Metered dose inhaler
US20040019025A1 (en) * 2000-04-18 2004-01-29 Gavin Brian Charles Medical compositions comprising (r,r)-formoterol and rofleponide
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
US20020076382A1 (en) * 2000-08-04 2002-06-20 Kaplan Leonard W. Formulations of mometasone and a bronchodilator for pulmonary administration
US20040050385A1 (en) * 2000-10-20 2004-03-18 Bonney Stanley George Inhaler
GB0030171D0 (en) * 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol
US20020189610A1 (en) * 2001-02-01 2002-12-19 Karl-Heinz Bozung Pharmaceutical compositions containing an ipratropium salt and a betamimetic
GB0105560D0 (en) * 2001-03-07 2001-04-25 Glaxo Group Ltd Pharmaceutical formulations
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
JP2003221335A (ja) * 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
NZ541168A (en) * 2002-12-10 2008-10-31 Sepracor Inc Levalbuterol salt
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders

Also Published As

Publication number Publication date
AU2005281511B2 (en) 2011-03-31
KR20070102659A (ko) 2007-10-19
MX2007002899A (es) 2007-05-16
AU2005281511A1 (en) 2006-03-16
CA2580019A1 (en) 2006-03-16
BRPI0515103A (pt) 2008-07-08
EP1791534A1 (en) 2007-06-06
JP2008512434A (ja) 2008-04-24
WO2006027595A1 (en) 2006-03-16
IL181828A0 (en) 2007-07-04
US20070264202A1 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
EA200700600A1 (ru) Фармацевтическая композиция, содержащая изомер бета-миметического агента и антихолинергический агент
EP2054411A4 (en) NOVEL COMPOUNDS, ISOMERS THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP1861357A4 (en) NEW COMPOUNDS, ISOMERS THEREOF, OR PHARMACEUTICALLY SALTS SUCH AS VANILLOIDREZEPTORANTAGONIST, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CY1118292T1 (el) Ρυθμιστες φαρμακοκινητικων ιδιοτητων των θεραπευτικων
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
UY30440A1 (es) Nuevos compuestos
TW200613243A (en) Novel compounds
WO2008010921A3 (en) Modulators of pharmacokinetic properties of therapeutics
NO20074567L (no) Glucagonreseptorantagoniser, fremstilling og terapeutisk anvendelse
TW200745111A (en) New compounds
HN2011000874A (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
UA92670C2 (ru) Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
TW200606164A (en) New compounds
WO2007078895A3 (en) Modified release formulations of tramadol and uses thereof
CO6290644A2 (es) Antagonista del receptor opioide selectivo kappa.
BRPI0618479A2 (pt) pirrolpiridinas composição farmacêutica que as contém
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
BRPI0518993A2 (pt) composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto
SE0400284D0 (sv) Novel compounds
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
EP2077846A4 (en) BENZOXAZEPINE COMPOUNDS, PREPARATION THEREOF AND USE THEREOF
EA200702612A1 (ru) Соединения бензимидазолкарбоксамида в качестве агонистов рецепторов 5-нт
DE602006018713D1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
EA200970158A1 (ru) Производные хинуклидина в качестве антагонистов м3
TW200800984A (en) New compounds